Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • BMS CA209-153

    A Phase IIIb/IV Safety Trial of Nivolumab (BMS- 936558) in Subjects with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Systemic Regimen.

  • CTSU E5508

    A Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC.

  • SWOG S1400

    Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer (Screening Step) Lung-MAP Study

Showing trials 1-3 of 3

Also in this Section